Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Withdrawn 1Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Head & Neck 2Gynecologic 2Breast 2Sarcoma 1Dermatologic 1CNS 1

Conditions

Rectal Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Hepatoblastoma 1HER2 Positive Advanced Gastric Cancer 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Tissue Banks × Gastrointestinal × Clear all
NCT06574620 2026-01-16

ACCELERATE

British Columbia Cancer Agency

Phase NA Recruiting
200 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT04223102 2023-08-02

Microbiome and Rectal Cancer

University of South Florida

Phase NA Active not recruiting
40 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05348161 2022-04-27

Dynamic Multiomics Evaluation of Anti-HER2 and Immunotherapy in HER2 Positive Gastric Cancer

Peking University

Phase NA Unknown
100 enrolled
Gastrointestinal

HER2 Positive Advanced Gastric Cancer

NCT00228683 2013-11-26

Hepatoblastoma Biology Study and Tissue Bank

Emory University

Phase NA Withdrawn
Gastrointestinal

Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡